- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vectus Biosystems Ltd (VBS)
Vectus Biosystems Ltd stock price live, this page displays ASX VBS stock exchange data. View the VBS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vectus Biosystems Ltd real time stock price chart below.
What Is the Vectus Biosystems Ltd Stock Price Today?
The Vectus Biosystems Ltd stock price today is 0.060.
What Is the Stock Symbol for Vectus Biosystems Ltd?
The stock symbol for Vectus Biosystems Ltd is ""VBS.""
What Stock Exchange Does Vectus Biosystems Ltd Trade On?
Vectus Biosystems Ltd is listed and trades on the Sydney stock exchange.
Is Vectus Biosystems Ltd a Good Stock to Buy?
Determining whether Vectus Biosystems Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VBS quote. (ISIN: AU000000VBS9)
What Is the Vectus Biosystems Ltd Stock Price Today?
The Vectus Biosystems Ltd stock price today is 0.060.
What Is the Stock Symbol for Vectus Biosystems Ltd?
The stock symbol for Vectus Biosystems Ltd is ""VBS.""
What Stock Exchange Does Vectus Biosystems Ltd Trade On?
Vectus Biosystems Ltd is listed and trades on the Sydney stock exchange.
Is Vectus Biosystems Ltd a Good Stock to Buy?
Determining whether Vectus Biosystems Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VBS quote. (ISIN: AU000000VBS9)
Sydney
Currency in AUD
0.060
0.000(0.00%)
Delayed Data·
Fair Value
An estimate of a Vectus Biosystems's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.060
0.060
52 wk Range
0.037
0.089
VBS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VBS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Vectus Biosystems's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0600.060
52 wk Range
0.0370.089
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
VBS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vectus Biosystems's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Vectus Biosystems Ltd Company Profile
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for cardiovascular fibrosis and systolic blood pressure, as well as treatments for kidney, liver, and lung fibrosis. Its lead compound is VB0004, currently under phase Ib clinical human trial, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure; VB4-A32 for the treatment of liver fibrosis; VB4-A79 for the treatment of lung fibrosis; and VB4-P5 for the treatment of renal fibrosis. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops Accugen consisting of AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.
Compare VBS to Peers and Sector
Metrics to compare | VBS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVBSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −4.3x | −0.5x | |
PEG Ratio | −0.16 | −0.06 | 0.00 | |
Price/Book | 7.9x | 2.9x | 2.6x | |
Price / LTM Sales | 3.6x | 14.9x | 3.3x | |
Upside (Analyst Target) | - | 283.8% | 45.1% | |
Fair Value Upside | Unlock | 0.8% | 7.4% | Unlock |
Earnings
Latest Release
Feb 21, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
393.71K / --
FAQ
What Stock Exchange Does Vectus Biosystems Trade On?
Vectus Biosystems is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Vectus Biosystems?
The stock symbol for Vectus Biosystems is "VBS."
What Is the Vectus Biosystems Market Cap?
As of today, Vectus Biosystems market cap is 3.20M.
What Is Vectus Biosystems's Earnings Per Share (TTM)?
The Vectus Biosystems EPS (TTM) is -0.04.
From a Technical Analysis Perspective, Is VBS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Vectus Biosystems Stock Split?
Vectus Biosystems has split 0 times.
How Many Employees Does Vectus Biosystems Have?
Vectus Biosystems has 0 employees.
What is the current trading status of Vectus Biosystems (VBS)?
As of 04 Aug 2025, Vectus Biosystems (VBS) is trading at a price of 0.06, with a previous close of 0.06. The stock has fluctuated within a day range of 0.06 to 0.06, while its 52-week range spans from 0.04 to 0.09.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.